Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ:IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Tuesday, February 8th, 2024 at 2:30 PM ET.
Related news for (IPSC)
- Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
- Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
- Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
- Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
- Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update